Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 10% of free cash flow, leaving room to grow it and fund buybacks. Last year: $78.4M dividends + $0 buybacks = $78.4M returned on $785.4M FCF.
1 consecutive years of dividend increases · -65%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 4 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 4 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 8% against ROIC 4% — 3% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cost of Revenue | 92.7 | 92.6 | 92.8 | 93.3 |
| Gross Profit | 7.3 | 7.4 | 7.2 | 6.7 |
| SG&A | 5.3 | 5.4 | 5.4 | 5.0 |
| Operating Income | 6.4 | 2.0 | 1.7 | 1.7 |
| Income Tax | 0.8 | 0.4 | 0.4 | 0.4 |
| Net Income | 4.7 | 0.7 | 0.6 | 0.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on INGM: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $28.40 today, the market must believe free cash flow compounds 3.6%/yr for a decade (off $488.3M on the 3-yr avg basis).
On the basis ($460.7M) the requirement is 4.4%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 3.6% is more conservative than its 1-yr track record.
Default is 9.4% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.23B shares (market data) · net debt $1.33B
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~9.5% on $3.20B of debt.
Cash of $1.86B fully covers short-term debt of $449.6M.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $52.56B 100.0% | $47.98B 100.0% | $48.04B 100.0% | $50.82B 100.0% |
| Cost of Revenue | $49.05B 93.3% | $44.54B 92.8% | $44.49B 92.6% | $47.13B 92.7% |
| Gross Profit | $3.50B 6.7% | $3.44B 7.2% | $3.55B 7.4% | $3.69B 7.3% |
| Selling, General & Admin | $2.61B 5.0% | $2.59B 5.4% | $2.58B 5.4% | $2.72B 5.3% |
| Total Operating Expenses | $2.63B 5.0% | $2.63B 5.5% | $2.60B 5.4% | $444.5M 0.9% |
| Operating Income | $876.9M 1.7% | $817.9M 1.7% | $944.3M 2.0% | $3.25B 6.4% |
| Interest Expense | $302.6M 0.6% | $338.4M 0.7% | $380.2M 0.8% | $320.2M 0.6% |
| Interest & Investment Income | $45.7M 0.1% | $45.3M 0.1% | $35.0M 0.1% | $22.9M 0.0% |
| Other Income (Expense), net | -$346.2M -0.7% | -$372.1M -0.8% | -$421.8M -0.9% | -$434.4M -0.9% |
| Pretax Income | $530.8M 1.0% | $445.9M 0.9% | $522.5M 1.1% | $2.81B 5.5% |
| Income Tax Expense | $202.9M 0.4% | $181.6M 0.4% | $169.8M 0.4% | $420.1M 0.8% |
| Net Income | $327.9M 0.6% | $264.2M 0.6% | $352.7M 0.7% | $2.39B 4.7% |
| Per Share | ||||
| EPS (Basic) | $1.40 | $1.18 | $1.59 | $10.77 |
| EPS (Diluted) | $1.39 | $1.18 | $1.59 | $10.77 |
| Weighted Avg Shares (Basic) | 234.9M | 224.6M | 222.4M | 222.4M |
| Weighted Avg Shares (Diluted) | 235.4M | 224.7M | 222.4M | 222.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 19 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNX | $18.9B | 23.8× | 11.5× | 0.3× | 6.9% | 7.0% | 1.3% | 9.8% | 6.3% | 1.2× | 184 |
| WCC | $16.7B | 26.3× | 17.1× | 0.7× | 7.8% | 21.1% | 2.7% | 12.7% | 5.9% | 4.4× | 167 |
| GPC | $16.7B | 257.2× | 14.1× | 0.7× | 3.5% | 36.8% | 0.3% | 1.5% | 0.7% | 3.0× | 339 |
| WSO | $12.6B | 24.8× | 16.0× | 1.8× | -5.0% | 28.0% | 6.9% | 17.9% | 17.9% | -0.6× | 205 |
| AIT | $10.7B | 26.9× | 18.9× | 2.2× | 8.8% | 30.3% | 8.3% | 22.3% | 19.5% | 0.2× | 153 |
| ARW | $10.6B | 19.1× | 13.9× | 0.3× | 10.5% | 11.2% | 1.9% | 8.7% | 5.9% | 2.9× | 140 |
| HSIC | $9.5B | 26.0× | 10.4× | 0.7× | 4.0% | 31.1% | 3.0% | 12.3% | 9.9% | 0.6× | 149 |
| CNM | $8.2B | 19.2× | 11.0× | 1.1× | 2.8% | 26.9% | 5.8% | 22.1% | 10.6% | 2.1× | 85 |
| POOL | $7.4B | 19.0× | 13.7× | 1.4× | -0.4% | 29.7% | 7.7% | 34.3% | 17.0% | 1.9× | 117 |
| AVT | $7.3B | 22.0× | — | 0.3× | 24.5% | 10.4% | 1.2% | 6.7% | 4.1% | — | 138 |
| MSM | $6.8B | 30.4× | 17.7× | 1.7× | 6.4% | 40.9% | 5.6% | 15.6% | 11.7% | 1.0× | 113 |
| INGM | $6.5B | 20.4× | 7.3× | 0.1× | 9.5% | 6.7% | 0.6% | 7.7% | 4.4% | 1.2× | 33 |
| SITE | $4.8B | 32.9× | — | 1.0× | 3.6% | 34.8% | 3.2% | 9.1% | 7.4% | — | 74 |
| LKQ | $4.7B | 7.9× | 3.1× | 0.3× | -1.2% | 38.6% | 4.5% | 9.3% | 9.3% | -0.2× | 114 |
| REZI | $2.8B | — | 7.9× | 0.4× | 10.5% | 29.4% | -7.1% | -18.1% | -8.6% | 3.7× | 101 |
| BCC | $2.8B | 22.3× | 8.0× | 0.4× | -4.8% | — | 2.1% | 6.4% | 5.3% | -0.1× | 62 |
| DXPE | $2.7B | 32.5× | 17.3× | 1.3× | 11.9% | 31.5% | 4.4% | 17.8% | 6.7% | 2.8× | 61 |
| PLUS | $2.4B | 18.5× | 10.4× | 1.0× | 22.1% | 25.2% | 5.4% | 12.4% | 12.4% | -2.1× | 62 |
| CNXN | $2.2B | 26.6× | 18.2× | 0.8× | 2.5% | 18.8% | 2.9% | 9.2% | 9.2% | -1.8× | 49 |
| GIC | $1.7B | 23.4× | 15.1× | 1.2× | 4.8% | 35.5% | 5.2% | 23.0% | 23.0% | -0.6× | 26 |
Peers = companies sharing INGM's sector (Wholesale-Computers & Peripheral Equipment & Software) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Earns -1.87pts against its cost of capital — capital is being consumed, not created.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2022 | 7.3% | 6.4% | 4.7% |
| FY2023 | 7.4% | 2.0% | 0.7% |
| FY2024 | 7.2% | 1.7% | 0.6% |
| FY2025 | 6.7% | 1.7% | 0.6% |
The spread is -1.87pts and would invert under a ±2% move in WACC, so the verdict rests on the cost-of-capital assumption rather than on the business.
Leverage and buybacks account for 3 points of the 8% return on equity in FY2025. The business earns 4% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$851M of goodwill — 10% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2022 | 74.4% | 9.4% (today's — no rate published for this year) | 65.0pts |
| FY2023 | 8.4% | 7.8% | 0.6pts |
| FY2024 | 7.6% | 8.4% | -0.8pts |
| FY2025 | 8.7% | 7.9% | 0.7pts |
| Now | 4.4% | 9.4% | -5.0pts |
Cash conversion of 0.63x sits below the level that would make the earnings clearly cash-backed.
| Step | Amount | Running total |
|---|---|---|
| Net income | $328M | $328M |
| Share-based comp | $21M | $349M |
| Other non-cash & working capital | $567M | $916M |
| Operating cash flow | $916M | $916M |
| Capex | −$131M | $785M |
| Free cash flow | $785M | $785M |
| FCF after SBC | $764M | $764M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2023 | -5.5% | not reported | not reported |
| FY2024 | -0.1% | 5.1% | 5.2 points |
| FY2025 | 9.5% | 11.6% | 2.1 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2022 | not reported | not reported | not reported | not reported |
| FY2023 | 68.3 days | 38.2 days | 75.7 days | 30.8 days |
| FY2024 | 71.9 days | 38.5 days | 82 days | 28.4 days |
| FY2025 | 73.2 days | 37 days | 89 days | 21.2 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2022 | not reported |
| FY2023 | 1.6 percent |
| FY2024 | -0.4 percent |
| FY2025 | -2.8 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 2 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Shares outstanding are up 6% since FY2022 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Covers interest 2.0x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.90x |
| 5% | 2.75x |
| 10% | 2.61x |
| 15% | 2.46x |
| 20% | 2.32x |
| 25% | 2.17x |
| 30% | 2.03x |
| 35% | 1.88x |
| 40% | 1.74x |
| 45% | 1.59x |
| 50% | 1.45x |
| 55% | 1.30x |
| 60% | 1.16x |
Balance sheet at 2025-12-27. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $28.40, free cash flow must compound 4.38%/yr for 10 years. It has no positive compounding record to compare against.
The implied rate has been matched or beaten in 1 of the last 1 years.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-23 | Hornstein Carolyn SVP, Controller & CAO | Tax withholding | 912 | $27.50 | $25k |
| 2026-10-23 | Aragone Augusto Executive VP, Secretary & GC | Tax withholding | 9,789 | $27.50 | $269k |
| 2026-10-23 | Zilis Michael Executive VP & CFO | Tax withholding | 18,008 | $27.50 | $495k |
| 2026-10-23 | Bay Paul D Chief Executive Officer | Tax withholding | 23,983 | $27.50 | $660k |
| 2026-10-23 | Sherman Scott D Executive VP, Human Resources | Tax withholding | 12,985 | $27.50 | $357k |
| 2026-09-15 | 10 co-filers Group filing | Open-market saleindirect | 1,968,750 | $27.19 | $53.5m |
| 2026-09-10 | 10 co-filers Group filing | Open-market saleindirect | 13,125,000 | $27.19 | $356.8m |
| 2026-06-15 | 10 co-filers Group filing | Open-market saleindirect | 5,167,069 | $29.03 | $150.0m |
| 2026-06-15 | 2 co-filers Executive VP, Secretary & GC | 10b5-1 plan sale | 10,000 | $30.00 | $300k |
| 2026-06-12 | 2 co-filers Executive VP, Secretary & GC | 10b5-1 plan sale | 50,000 | $29.30 | $1.5m |
| 2026-05-14 | Alvaro Felicia Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-14 | Haussler Jakki L. Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-14 | Ashmore Craig W Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-14 | Wienbar Sharon L Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-14 | Stone Heisz Leslie Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-14 | Monie Alain Director | Grant | 7,031 | $0.00 | $0 |
| 2026-05-07 | 10 co-filers Group filing | Open-market saleindirect | 14,471,153 | $24.96 | $361.2m |
| 2026-03-30 | 10 co-filers Group filing | Open-market saleindirect | 1,348,314 | $21.36 | $28.8m |
| 2026-03-09 | 10 co-filers Group filing | Open-market saleindirect | 12,499,999 | $21.36 | $267.0m |
| 2026-03-04 | 2 co-filers SVP, Controller & CAO | Grant | 8,407 | $0.00 | $0 |
| 2026-03-04 | 2 co-filers Executive VP, Secretary & GC | Grant | 25,222 | $0.00 | $0 |
| 2026-03-04 | 2 co-filers Executive VP & CFO | Grant | 37,833 | $0.00 | $0 |
| 2026-03-04 | 2 co-filers Chief Executive Officer | Grant | 168,146 | $0.00 | $0 |
| 2026-03-04 | 2 co-filers Executive VP, Human Resources | Grant | 25,222 | $0.00 | $0 |
| 2026-03-03 | 2 co-filers SVP, Controller & CAO | Tax withholding | 597 | $21.35 | $13k |
| 2026-03-03 | 2 co-filers Executive VP, Secretary & GC | Tax withholding | 1,424 | $21.35 | $30k |
| 2026-03-03 | 2 co-filers Executive VP & CFO | Tax withholding | 2,601 | $21.35 | $56k |
| 2026-03-03 | 2 co-filers Chief Executive Officer | Tax withholding | 13,874 | $21.35 | $296k |
| 2026-03-03 | 2 co-filers Executive VP, Human Resources | Tax withholding | 1,853 | $21.35 | $40k |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.